| FemmePhase
FemmePhase is a new dietary supplement that alleviates
three of the major concerns that women have when passing through
menopause:
FemmePhase works by improving the function of
the glands and organs that control ovulation and menstruation and
by enhancing blood circulation.
Menopause marks the end of a woman’s menstruation and her
reproductive lifespan. It usually occurs between the ages of 35
and 55. The hormonal changes that occur before and after the cessation
of ovulation and menstruation are thought to reflect the aging process.
Imbalances in the hormonal interplay between the hypothalamus, the
pituitary, and the ovaries cause the many, varied symptoms that
make up the menopausal syndrome. These include irregular cycles,
missed periods, hot flashes, night sweats, palpitations, emotional
fragility and depression, headaches, memory loss, insomnia, loss
of libido, vaginal dryness, dry skin.
However, these same alterations in hormonal chemistry
are also felt to contribute to the major disorders of aging for
women – the atherosclerosis underlying heart disease and stroke
and the loss of bone mass leading to osteoporosis and increased
rates of bone fracture.
When passing through menopause, the ovaries lose
ability to produce estrogen and progesterone. The hypothalamus tries
to adjust for this loss by temporarily increasing levels of follicle
stimulating hormone [FSH] and luteinizing hormone [LH], hormones
that stimulate estrogen production. Also, the adrenal glands and
fat cells take over some level of estrogen production. Many women
pass through this period of adjustment with few symptoms.
However, menopausal syndrome is epidemic among
American women because a number of contributing factors keep the
varied regulating hormones in imbalance:
- Stress from overwork
- Poor nutrition
- Lack of exercise
- Excessive intake of synthetic hormones from
animal foods
- Excessive exposure to chemical pollutants
- Eating disorders including anorexia and bulimia
- Surgical removal of the uterus and ovaries
A number of studies indicate that FemmePhase is a valuable supplement
for the varied causes and symptoms of menopause, including the broader
imbalances that accompany aging.
In a study carried out at the Shanghai Center for Modern Traditional
Chinese Medicine Technology, 50 women with menopausal syndrome were
treated with FemmePhase. Their ages ranged from: 44 - 60 years.
Their symptoms included various levels of anxiety, emotional instability,
headache and dizziness, tinnitus and blockage of hearing, oppressive
sensations of the chest, palpitations, restlessness, anger, hot
flashes, spontaneous sweating, aching of the legs and low back,
uncontrollable crying, and depression.
After taking FemmePhase (shortest administration
period, 1 month; longest, 3 months), 30 patients experienced complete
relief of symptoms, 13 experienced marked improvement, and three
some improvement. Of the patients with complete relief of symptoms,
none of the symptoms had returned six months after discontinuation
of treatment.
In a second study the FemmePhase formula was evaluated
in both men (68) and women (82) as a treatment for neurasthenia.
Neurasthenia is a disorder of nervous exhaustion that shares many
symptoms with menopausal syndrome, including depression, irritability,
lack of focus, memory loss, insomnia and dream-disturbed sleep,
dizziness and headache, limb pain, and various autonomic nervous
system disorders. After three months of administration of the formula,
75 cases had fully recovered, 48 patients experienced marked improvement,
16 were noted as improved and 11 cases gained no improvement.
A third study looked at the use of FemmePhase
in treating angioneurotic headaches. Angioneurotic headaches are
characterized by spasms of the blood vessels resulting from disturbances
of the vasomotor system. Of the 84 patients in the study, 68 were
female and 16 male ranging in age from 17 to 52 years. They experienced
1+ headache per month with an average duration of the condition
of 2.5 years. The headaches were experienced as frontal, bilateral,
vertex, or occipital with throbbing, distending, pounding, or stabbing
pain. Accompanying symptoms included light-headedness, irritability,
insomnia, irregular menses in the female patients, and depression.
After a course of treatment with the formula,
54 cases experienced recovery in which all symptoms disappeared,
rheoencephalogram readings improved indicating normalization of
blood vessel tension, and there was no recurrence of headache one
year later. 25 patients experienced improvement in which headaches
and other symptoms disappeared and headache returned three months
after treatment. Only 5 cases experienced no improvement.
According to Subhuti Dharmananda in his paper The Endocrine
Effect of Chinese Medicine, “Chinese herbs act by stimulating
the production of hormones, altering the condition of hormone receptors
or changing the rate of catabolism of hormones, rather than by providing
the hormones or hormone analogs that function the same as hormones.”
In the case of FemmePhase, pharmacodynamic studies
in animals have revealed that the formula is capable of markedly
increasing the estrogen receptor levels of the pituitary gland,
hypothalamus, and ovaries in aged rats.
While the ability of FemmePhase to increase glandular
estrogen receptor levels is a likely contributor to its efficacy,
the formula is also affecting the autonomic nervous system. Hot
flashes, the most common menopausal symptom, are due to instability
of the brain’s relay system, its neurotransmitters, which
are affected by the lowered levels of estrogen in the blood stream
as menopause progresses. This instability affects our autonomic
nervous system (ANS). It is the ANS that is responsible for our
body’s thermostatic control, contraction and dilation of the
blood vessels and skin pores, perspiration, and other automatic
physiological responses of our body.
The apparent ability of FemmePhase to reduce hot
flashes and angioneurotic headaches indicates that it has a positive
impact on neurotransmitter function in regulating the hypothalamic,
pituitary, ovarian homeostat.
FemmePhase has been found to improve the blood circulation of the
heart and brain by promoting vessel dilation and inhibiting the
clumping of red blood corpuscles, thus increasing blood flow.
The formula was originally designed to treat the symptoms that follow
cerebrovascular accident or stroke. In a study of 98 post stroke
cases, including 56 men and 42 women, 72 patients showed marked
recovery after a course of treatment with the herbal formula.
Numerous animal studies indicate that the nutrient
combination in the formula improved microcirculation in the capillaries,
inhibited formation of thromboxane A2 to aid in prevention of blood
clots, and reversed platelet aggregation and elevations of blood
and plasma viscosity. Other animal studies have found that this
formula stimulates a protective mechanism against heart muscle cell
deterioration.
All of the benefits of improved blood flow including
improved vessel dilation and lowered viscosity should be of great
benefit to women following menopause who regularly ingest the ingredients
in FemmePhase. This improved blood flow will also have an additional
benefit in preserving the function of the organs and glands that
determine healthy endocrine function as women age.
Improved blood flow can also make a positive contribution to the
prevention of bone loss in postmenopausal women. After menopause,
bone loss accelerates for 3-5 years, at a rate of from 1.5% to 5%
per year. Bone loss then continues at a lower level of around 1%
to 1.5% loss per year on average.
Six of the ten herbs in FemmePhase are commonly
used in China in the treatment and reversal of Avascular Necrosis
of The Femoral Head. In this severe disorder, the head of the femur
at the hip collapses from a lack of blood flow and that destroys
bone tissue. It is commonly a result of chronic use of corticosteroid
therapy.
The herbs in FemmePhase are central to the restoration
of blood flow and bone mass density in this condition. Angelica
sinensis and cordyceps are thought to be the chief herbs that assist
in this disorder and are central herbs in the FemmePhase formula.
While it diminishes symptoms of menopausal syndrome, FemmePhase
should also provide women with protection against osteoporosis.
[A separate formula from Tango Advanced Nutrition, OsteoPhase, regulates
calcium homeostasis in a manner that is directly beneficial for
osteoporosis.]
Clinical trials indicate that FemmePhase is capable of effecting
regulatory changes of the endocrine and circulatory systems such
that many of the signs of aging, including those of menopause are
either ameliorated or even alleviated.
The formula can be taken by women at the earliest
signs of changes that indicate the approach of menopause to ease
them through the transition with minimal symptoms. After menopause,
FemmePhase can be taken regularly to continue to assist in maintaining
optimal endocrine, circulatory and skeletal health.
Menopausal syndrome with the following symptoms: hot flashes and
night sweats, dryness of the skin, poor memory and concentration,
depression, tearfulness, anxiety, insomnia, and loss of libido.
2 tablets, 2 times daily. For persistent insomnia, take an additional
2 capsules at bedtime, or follow practitioner’s advice. Symptom
alleviation is usually evident after 2 or 4 bottles, after which
FemmePhase can be taken at a rate of 1 tablet, 2 times daily for
health maintenance.
Through animal studies, FemmePhase was not found to induce any toxicologic
reactions. Side effects and other adverse reactions have not been
detected during human clinical studies.
Pharmacologic Actions of FemmePhase Ingredients
Ingredients
Traditional actions and indications: Nourishes the blood, promotes
the flow of blood, regulates the menses, relieves pain, moistens
the intestines and relieves constipation.
Clinical effects: Improves microcirculation and
vessel dilation, thus increasing blood flow rate and preventing
hemagglutination. Helps control serum cholesterol. Has calming,
pain relieving, and anti-inflammatory effects.
Clinical effects: Has vessel dilation and anti-platelet agglutination
effects. Major constituent is capable of penetrating the blood-brain
barrier and being stored in the brain stem, thus improving the dilation-contraction
function of the blood vessels of the brain. Has sedating and pain
relieving effects; alleviates spasms; has antihypertensive effect.
Clinical effects: Improves microcirculation and thus blood flow,
promotes the establishment of collateral blood vessels. Promotes
tissue repair and regeneration, inhibits overproliferation of fibrous
cells. Has sedating effect.
Clinical effects: Contains more ginsenosides than ginseng; alleviates
fatigue, has an overall strengthening effect. Strengthens the heart;
reduces myocardial oxygen consumption; dilates the vessels; reduces
artery pressure; raises coronary blood flow.
Clinical effects: Improves bone marrow function; accelerates red
blood cell production, has excitatory effect on smooth muscle of
the intestines, blood vessels, and bronchi, dilates the coronary
artery, relieves angina pectoris, improves low cardiac output.
Clinical effects: Has mild antiperistalsis effect on the stomach
and intestines. Has sedating effect; has antihypertensive effect;
promotes urination.
Clinical effects: Raises blood pressure during which blood flow
through the coronary artery, brain, and kidneys is increased, alleviates
allergic reactions by inhibiting the release of anaphylaxin.
Clinical effects: Increases immunity, lowers total serum lipid levels,
thus alleviating the formation of atheromatous lesions, and has
sedating and sleep-promoting effects.
Clinical effects: Reduces menstrual pain, abdominal pain, trauma
pain, moistens the intestines to lessen constipation.
Clinical effects: Stops cough, promotes the discharge of puss, soothes
sore throat, and directs the effects of other herbs to the upper
body.
|
